These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 20406245)
1. Therapeutic angiogenesis for the management of refractory angina: current concepts. Attanasio S; Schaer G Cardiovasc Ther; 2011 Dec; 29(6):e1-e11. PubMed ID: 20406245 [TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory angina pectoris. Gowda RM; Khan IA; Punukollu G; Vasavada BC; Nair CK Int J Cardiol; 2005 May; 101(1):1-7. PubMed ID: 15860376 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806 [TBL] [Abstract][Full Text] [Related]
4. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]
5. [Cardiac shock wave therapy--a new method for treatment of advanced coronary disease and refractory angina]. Sobczak M; Kasprzak JD Kardiol Pol; 2010 Dec; 68(12):1391-6. PubMed ID: 21174300 [TBL] [Abstract][Full Text] [Related]
7. The future of therapeutic myocardial angiogenesis. Boodhwani M; Sodha NR; Laham RJ; Sellke FW Shock; 2006 Oct; 26(4):332-41. PubMed ID: 16980878 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis for the treatment of inoperable coronary disease: the future. Sellke FW; Laham R; Suuronen EJ; Ruel M Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):184-8. PubMed ID: 16959748 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy and angiogenesis in patients with coronary artery disease. Kastrup J Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1127-38. PubMed ID: 20670190 [TBL] [Abstract][Full Text] [Related]
10. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects. Guo M; Shi JH; Wang PL; Shi DZ J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278 [TBL] [Abstract][Full Text] [Related]
11. Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological Technologies. Gallone G; Baldetti L; Tzanis G; Gramegna M; Latib A; Colombo A; Henry TD; Giannini F JACC Cardiovasc Interv; 2020 Jan; 13(1):1-19. PubMed ID: 31918927 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in the human heart: gene and cell therapy. Tirziu D; Simons M Angiogenesis; 2005; 8(3):241-51. PubMed ID: 16308736 [TBL] [Abstract][Full Text] [Related]
17. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery. Morrison DA; Sacks J Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention. Holper EM; Addo T Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692 [TBL] [Abstract][Full Text] [Related]
19. Refractory Angina: the Current State of Mechanical Therapies. Amritphale A; Amritphale N Curr Cardiol Rep; 2019 Apr; 21(6):46. PubMed ID: 31011835 [TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction--an obstacle of therapeutic angiogenesis. Sun L; Bai Y; Du G Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]